Location History:
- Luton, GB (1981 - 1991)
- Lutan, GB (1999)
- Stevenage, GB (1999 - 2003)
Company Filing History:
5 out of 1,168 
2 out of 2,198 
2 out of 281 
Years Active: 1981-2003
Title: Frank Ellis: Innovator in Anti-Inflammatory Research
Introduction
Frank Ellis is a renowned inventor based in Stevenage, GB, with a notable portfolio of nine patents. His work primarily revolves around the development of innovative compounds aimed at combating inflammatory diseases. Ellis has made significant contributions to the field of pharmacology, demonstrating how targeted chemical compounds can lead to advancements in medical treatments.
Latest Patents
Among his latest patents are two significant inventions related to 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives. The first patent discloses compounds of formula (I), where R, R1, and R2 are defined within the specification. This invention includes not only the compounds themselves but also methodologies for preparing these compounds, formulations that contain them, and their potential administration in treating inflammatory diseases. The second patent focuses on a series of 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives with broad anti-inflammatory properties. These derivatives inhibit leukocyte recruitment and activation while acting as agonists of the adenosine 2a receptor, showcasing their therapeutic potential.
Career Highlights
Throughout his career, Frank Ellis has collaborated with leading pharmaceutical companies such as Glaxo Group Limited and SmithKline Beecham Corporation. His work has placed him at the forefront of research and development within the pharmaceutical industry, significantly impacting how inflammatory diseases are treated.
Collaborations
During his tenure in the pharmaceutical sector, Ellis has had the privilege of working alongside esteemed colleagues, including Brian Cox and Stephen Swanson. These collaborations have not only enriched his own research but have also contributed to the collective advancement of knowledge in the field.
Conclusion
Frank Ellis’s contributions to the development of novel anti-inflammatory compounds illustrate the vital role of inventors in advancing medical science. With nine patents to his name, his work continues to inspire further research and innovation in the treatment of inflammatory diseases, highlighting the significance of dedicated inventors in addressing health challenges.